• Please log in or register to access this feature.

Review Article

You have free access to this content

Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions

  1. Y. Teuschl,
  2. K. Matz,
  3. M. Brainin*

Article first published online: 4 JUN 2012

DOI: 10.1111/j.1468-1331.2012.03757.x

Issue

European Journal of Neurology

European Journal of Neurology

Volume 20, Issue 1, pages 35–49, January 2013

Additional Information

How to Cite

Teuschl, Y., Matz, K. and Brainin, M. (2013), Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions. European Journal of Neurology, 20: 35–49. doi: 10.1111/j.1468-1331.2012.03757.x

Author Information

  1. Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria

*Correspondence: M. Brainin, Department for Clinical Neurosciences and Preventive Medicine Danube University Krems Dr.-Karl-Dorrek-Str. 30 A-3500 Krems, Krems, Austria (tel: +43 2732893 2814; fax: +43 2732893 4810; e-mail: Michael.Brainin@donau-uni.ac.at).

Publication History

  1. Issue published online: 22 DEC 2012
  2. Article first published online: 4 JUN 2012
  3. Manuscript Accepted: 19 APR 2012
  4. Manuscript Received: 17 FEB 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (552K)

References

  • 1
    Hénon H, Pasquier F, Leys D. Poststroke dementia. Cerebrovasc Dis 2006; 22: 61–70.
  • 2
    Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8: 1006–1018.
  • 3
    Leys D, Hénon H, Mackowiak-Cordoliani M-A, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4: 752–759.
  • 4
    Gamaldo A, Moghekar A, Kilada S, Resnick SM, Zonderman AB, O'Brien R. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 2006; 67: 1363–1369.
  • 5
    Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors > 75 years of age. Stroke 2003; 34: 2440–2444.
  • 6
    Popović IM, Serić V, Demarin V. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. J Neurol Sci 2007; 257: 185–193.
  • 7
    Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol 2010; 9: 895–905.
  • 8
    Appelros P, Andersson AG. Changes in Mini Mental State Examination score after stroke: lacunar infarction predicts cognitive decline. Eur J Neurol 2006; 13: 491–495.
    Direct Link:
  • 9
    Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz LM, Koschera A. Progression of cognitive impairment in stroke patients. Neurology 2004; 63: 1618–1623.
  • 10
    Richard E, Ligthart SA, Moll van Charante EP, van Gool WA. Vascular risk factors and dementia–towards prevention strategies. Neth J Med 2010; 68: 284–290.
  • 11
    Lee Y, Back JH, Kim J, et al. Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr 2010; 22: 174–187.
  • 12
    Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237–2242.
  • 13
    Cumming TB, Brodtmann A. Can stroke cause neurodegenerative dementia? Int J Stroke 2011; 6: 416–424.
    Direct Link:
  • 14
    Ankolekar S, Geeganage C, Anderton P, Hogg C, Bath PMW. Clinical trials for preventing post stroke cognitive impairment. J Neurol Sci 2010; 299: 168–174.
  • 15
    Ploughman M, McCarthy J, Bossé M, Sullivan HJ, Corbett D. Does treadmill exercise improve performance of cognitive or upper-extremity tasks in people with chronic stroke? A randomized cross-over trial. Arch Phys Med Rehabil 2008; 89: 2041–2047.
  • 16
    Quaney BM, Boyd LA, McDowd JM, et al. Aerobic exercise improves cognition and motor function poststroke. Neurorehabil Neural Repair 2009; 23: 879–885.
  • 17
    Liu-Ambrose T, Eng JJ, Boyd LA, et al. Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment. BMC Neurol 2010; 10: 14.
  • 18
    Rand D, Eng JJ, Liu-Ambrose T, Tawashy AE. Feasibility of a 6-month exercise and recreation program to improve executive functioning and memory in individuals with chronic stroke. Neurorehabil Neural Repair 2010; 24: 722–729.
  • 19
    Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004; 85: 1694–1704.
  • 20
    Angevaren M, Aufdemkampe G, Verhaar HJJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008; 3: CD005381.
  • 21
    Smith PJ, Blumenthal JA, Hoffman BM, et al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 2010; 72: 239–252.
  • 22
    Smith PJ, Blumenthal JA. Diet and neurocognition: review of evidence and methodological considerations. Curr Aging Sci 2010; 3: 57–66.
  • 23
    Serra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 2006; 64: S27–S47.
    Direct Link:
  • 24
    Wardle J, Rogers P, Judd P, et al. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med 2000; 108: 547–553.
  • 25
    Smith PJ, Blumenthal JA, Babyak MA, et al. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension 2010; 55: 1331–1338.
  • 26
    VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 2010; 9: 855–865.
  • 27
    Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565–575.
  • 28
    Stott DJ, MacIntosh G, Lowe GDO, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005; 82: 1320–1326.
  • 29
    Vogel T, Dali-Youcef N, Kaltenbach G, Andrès E. Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 2009; 63: 1061–1067.
    Direct Link:
  • 30
    Malouf R, Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 2003; 4: CD004393.
  • 31
    Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 2003; 4: CD004514.
  • 32
    Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008; 4: CD004514.
  • 33
    Isaac MGEKN, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008; 3: CD002854.
  • 34
    Chiu C-C, Su K-P, Cheng T-C, et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1538–1544.
  • 35
    Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006; 63: 1402–1408.
  • 36
    Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010; 304: 1903–1911.
  • 37
    Van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008; 71: 430–438.
  • 38
    Dangour AD, Allen E, Elbourne D, et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 2010; 91: 1725–1732.
  • 39
    Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JPE, Butler LT. Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 2009; 4: 227–242.
  • 40
    Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2009; 1: CD003120.
  • 41
    Cicerone KD, Dahlberg C, Malec JF, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005; 86: 1681–1692.
  • 42
    Cicerone KD, Langenbahn DM, Braden C, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil 2011; 92: 519–530.
  • 43
    Doornhein K, De Haan EHF. Cognitive training for memory deficits in stroke patients. Neuropsychol Rehabil 1998; 8: 393–400.
  • 44
    Hildebrandt H, Bussmann-Mork B, Schwendemann G. Group therapy for memory impaired patients: a partial remediation is possible. J Neurol 2006; 253: 512–519.
  • 45
    Rose FD, Brooks BM, Attree EA, et al. A preliminary investigation into the use of virtual environments in memory retraining after vascular brain injury: indications for future strategy? Disabil Rehabil 1999; 21: 548–554.
  • 46
    Fish J, Manly T, Emslie H, Evans JJ, Wilson BA. Compensatory strategies for acquired disorders of memory and planning: differential effects of a paging system for patients with brain injury of traumatic versus cerebrovascular aetiology. J Neurol Neurosurg Psychiatr 2008; 79: 930–935.
  • 47
    Sturm W, Willmes K. Efficacy of a reaction training on various attentional and cognitive functions in stroke patients. Neuropsychol Rehabil 1991; 1: 259–280.
  • 48
    Barker-Collo SL, Feigin VL, Lawes CMM, Parag V, Senior H, Rodgers A. Reducing attention deficits after stroke using attention process training: a randomized controlled trial. Stroke 2009; 40: 3293–3298.
  • 49
    Westerberg H, Jacobaeus H, Hirvikoski T, et al. Computerized working memory training after stroke-a pilot study. Brain Inj 2007; 21: 21–29.
  • 50
    Levine B, Schweizer TA, O'Connor C, et al. Rehabilitation of executive functioning in patients with frontal lobe brain damage with goal management training. Front Hum Neurosci 2011; 5: 9.
  • 51
    Liu KP, Chan CC, Lee TM, Hui-Chan CW. Mental imagery for promoting relearning for people after stroke: a randomized controlled trial. Arch Phys Med Rehabil 2004; 85: 1403–1408.
  • 52
    Liu KPY, Chan CCH, Wong RSM, et al. A randomized controlled trial of mental imagery augment generalization of learning in acute poststroke patients. Stroke 2009; 40: 2222–2225.
  • 53
    Särkämö T, Tervaniemi M, Laitinen S, et al. Music listening enhances cognitive recovery and mood after middle cerebral artery stroke. Brain 2008; 131: 866–876.
  • 54
    Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011; 1: CD006220.
  • 55
    Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166: 367–378.
  • 56
    Almeida OP, Garrido GJ, Alfonso H, et al. 24-month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage 2011; 55: 1480–1489.
  • 57
    European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457–507.
  • 58
    Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010; 153: 182–193.
  • 59
    Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220–2241.
  • 60
    Foster PP, Rosenblatt KP, Kuljiš RO. Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease. Front Neurol 2011; 2: 28.
  • 61
    Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke 2012; 43: 464–469.
View Full Article (HTML) Get PDF (552K)